harmonisation will simplify or complicate these developments? Differences in time
from submission to market between regulatory jurisdictions (e.g. United States and
European Union) could have major negative impacts on how these many advances
are brought into practical therapeutics. The global harmonisation of animal drug
regulations would, at a stroke, remove impediments to rapid drug approval and
subsequent marketing.
11 Conclusion
So we may ask, where will veterinary pharmacology be in 20 or 30 years time? As
can be appreciated from the discussion in this chapter, this question is particularly
difficult to answer. Any paradigm shift in the knowledge of disease control or
transformational change in the structure of drug regulatory agencies could dramati-
cally change the nature of the mid-twenty-first century armamentarium. Global
disease outbreaks could either decimate animal agriculture or alternatively speed
approval of novel therapeutic agents or even both. Increased development of ever
smaller and faster computing platforms linked to microfluidic platforms could
individualise drug therapy in ways difficult to comprehend today. The goal of this
review has not been to make iron-clad predictions but rather to stimulate thinking in
relation to harnessing developing technologies to improve animal health and, in the
case of food animals, without adversely risking human food safety.
References
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool.
J Mol Biol 215:403–410
Andersen L, Higby GJ (1995) The spirit of voluntarism. A legacy of commitment and contribution.
The United States Pharmacopeia 1820–1899. The United States Pharmacopeial Convention,
Rockville
Baynes RE, Xia XR, Imram M, Riviere JE (2008) Quantification of chemical mixture interactions
that modulate dermal absorption using a multiple membrane coated fiber array. Chem Res
Toxicol 21:591–599
Booker R, Boysen E (2005) Nanotechnology for dummies. Wiley, New York
Buur J, Baynes R, Smith G, Riviere J (2006) Use of probabilistic modeling within a physiologi-
cally based pharmacokinetic model to predict sulfamethazine residue withdrawal times in
edible tissues in swine. Antimicrob Agents Chemother 50:2344–2351
Buur JL, Baynes RE, Riviere JE (2008) Estimating meat withdrawal times in pigs exposed to
melamine contaminated feed using a physiologically based pharmacokinetic model. Reg
Toxicol Pharmacol 51:324–331
Craigmill AL (2003) A physiologically based pharmacokinetic model for oxytetracycline residues
in sheep. J Vet Pharmacol Ther 26:55–63
Cunningham MJ (2000) Genomics and proteomics: The new millennium of drug discovery and
development. J Pharmacol Toxicol Methods 44:291–300
Davis LE (1982) Veterinary Pharmacology – An Introduction to the Discipline. In: Booth NJ,
McDonald LE (eds) Veterinary Pharmacology and Therapeutics, 5th edn. Iowa State Univer-
sity Press, Ames
208 J.E. Riviere